9
NOV
Reports
Q3, 2023 earnings report expected
CLDX
Celldex Therapeutics Inc
41.75
0.11
(0.26%)
EPS
$-0.777143
Estimated Sales
$731.67K
Market Cap
$1.13B
Trade
Mentioned
CLDX
0.42 (1.02%)
S
41.64
B
41.79
@MarketUpdates
United Kingdomabout a year ago
Edited
9
NOV
Reports
Q3, 2023 earnings report expected
CLDX
Celldex Therapeutics Inc
41.75
0.11
(0.26%)
EPS
$-0.777143
Estimated Sales
$731.67K
Market Cap
$1.13B
Trade
1 Mentioned
CLDX
Celldex Therapeutics Inc